D-1550-2015 Class II Terminated

Recall Details

Hydromorphone 40 mg/ml + Bupivacaine 20 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Nationwide

All lots distributed between November 2014 and May 2015; 03162015@64, 6/14/2015; 04162015@53, 7/15/2015

D-0600-2018 Class I — HCG 5,000 IU/mL + Methylcobalamin 500 mcg/mL Injection 5 mL, Multi-Dose Vial, St (January 12, 2018)
D-1718-2015 Class II — Quad-Mix 4 Injectable, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Ph (June 2, 2015)
D-1473-2015 Class II — Estradiol 4 mg, Sterile Pellet, The Compounding Pharmacy of America, Inc., Knoxv (June 2, 2015)
D-1482-2015 Class II — Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml Clonidine 1,300 mcg/ml + Baclofen (June 2, 2015)
D-1666-2015 Class II — Bi-Mix Medium (30/1) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy (June 2, 2015)
D-1665-2015 Class II — Bi-Mix (20/1) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of Amer (June 2, 2015)
D-1695-2015 Class II — Lipovicine-Choline 100 mg/ml-Acorbic Acid 45 mg/ml Injectable, Multi-Dose Vial, (June 2, 2015)
D-1599-2015 Class II — Morphine 40 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy (June 2, 2015)
D-1626-2015 Class II — Progesterone 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, Th (June 2, 2015)
D-1584-2015 Class II — Mitomycin 40 mg/50 ml Sodium Chloride 0.9% Injection, Single Dose Syringe, The C (June 2, 2015)